1. Home
  2. QLGN vs BNRG Comparison

QLGN vs BNRG Comparison

Compare QLGN & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • BNRG
  • Stock Information
  • Founded
  • QLGN 1996
  • BNRG 2012
  • Country
  • QLGN United States
  • BNRG Israel
  • Employees
  • QLGN N/A
  • BNRG N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • BNRG
  • Sector
  • QLGN Health Care
  • BNRG
  • Exchange
  • QLGN Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • QLGN 7.4M
  • BNRG 6.2M
  • IPO Year
  • QLGN N/A
  • BNRG 2022
  • Fundamental
  • Price
  • QLGN $3.06
  • BNRG $1.68
  • Analyst Decision
  • QLGN
  • BNRG
  • Analyst Count
  • QLGN 0
  • BNRG 0
  • Target Price
  • QLGN N/A
  • BNRG N/A
  • AVG Volume (30 Days)
  • QLGN 3.7M
  • BNRG 122.2K
  • Earning Date
  • QLGN 11-13-2025
  • BNRG 09-30-2025
  • Dividend Yield
  • QLGN N/A
  • BNRG N/A
  • EPS Growth
  • QLGN N/A
  • BNRG N/A
  • EPS
  • QLGN N/A
  • BNRG N/A
  • Revenue
  • QLGN N/A
  • BNRG $387,000.00
  • Revenue This Year
  • QLGN N/A
  • BNRG N/A
  • Revenue Next Year
  • QLGN N/A
  • BNRG N/A
  • P/E Ratio
  • QLGN N/A
  • BNRG N/A
  • Revenue Growth
  • QLGN N/A
  • BNRG 843.90
  • 52 Week Low
  • QLGN $1.61
  • BNRG $1.50
  • 52 Week High
  • QLGN $8.81
  • BNRG $15.30
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 40.62
  • BNRG 43.37
  • Support Level
  • QLGN $2.90
  • BNRG $1.63
  • Resistance Level
  • QLGN $5.97
  • BNRG $1.75
  • Average True Range (ATR)
  • QLGN 0.54
  • BNRG 0.11
  • MACD
  • QLGN -0.20
  • BNRG 0.01
  • Stochastic Oscillator
  • QLGN 5.21
  • BNRG 25.00

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: